From what we understood from the report, the methodology was not to determine whether products made in Canada and offered over the counter to consumers complied with standards. The objective of the review was to determine whether Health Canada was taking the necessary steps to ensure that products in Canada were compliant. There's a difference between those two intents, and I think the intent has been a bit distorted.
On October 31st, 2024. See this statement in context.